388 related articles for article (PubMed ID: 31123853)
21. Boron neutron capture therapy (BNCT) translational studies in the hamster cheek pouch model of oral cancer at the new "B2" configuration of the RA-6 nuclear reactor.
Monti Hughes A; Longhino J; Boggio E; Medina VA; Martinel Lamas DJ; Garabalino MA; Heber EM; Pozzi ECC; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
Radiat Environ Biophys; 2017 Nov; 56(4):377-387. PubMed ID: 28871389
[TBL] [Abstract][Full Text] [Related]
22. Dosimetry and radiobiology at the new RA-3 reactor boron neutron capture therapy (BNCT) facility: application to the treatment of experimental oral cancer.
Pozzi E; Nigg DW; Miller M; Thorp SI; Heber EM; Zarza L; Estryk G; Monti Hughes A; Molinari AJ; Garabalino M; Itoiz ME; Aromando RF; Quintana J; Trivillin VA; Schwint AE
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S309-12. PubMed ID: 19380233
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effect of boron neutron capture therapy (BNCT) on field cancerized tissue: inhibition of DNA synthesis and lag in the development of second primary tumors in precancerous tissue around treated tumors in DMBA-induced carcinogenesis in the hamster cheek pouch oral cancer model.
Heber EM; Aromando RF; Trivillin VA; Itoiz ME; Nigg DW; Kreimann EL; Schwint AE
Arch Oral Biol; 2007 Mar; 52(3):273-9. PubMed ID: 17137553
[TBL] [Abstract][Full Text] [Related]
24. Boron neutron capture therapy for oral precancer: proof of principle in an experimental animal model.
Monti Hughes AM; Pozzi EC; Thorp S; Garabalino MA; Farías RO; González SJ; Heber EM; Itoiz ME; Aromando RF; Molinari AJ; Miller M; Nigg DW; Curotto P; Trivillin VA; Schwint AE
Oral Dis; 2013 Nov; 19(8):789-95. PubMed ID: 23410091
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model.
Heber EM; Hawthorne MF; Kueffer PJ; Garabalino MA; Thorp SI; Pozzi EC; Monti Hughes A; Maitz CA; Jalisatgi SS; Nigg DW; Curotto P; Trivillin VA; Schwint AE
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):16077-81. PubMed ID: 25349432
[TBL] [Abstract][Full Text] [Related]
26. Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases.
Trivillin VA; Garabalino MA; Colombo LL; González SJ; Farías RO; Monti Hughes A; Pozzi EC; Bortolussi S; Altieri S; Itoiz ME; Aromando RF; Nigg DW; Schwint AE
Appl Radiat Isot; 2014 Jun; 88():94-8. PubMed ID: 24360862
[TBL] [Abstract][Full Text] [Related]
27. Boron neutron capture therapy (BNCT) for the treatment of spontaneous nasal planum squamous cell carcinoma in felines.
Trivillin VA; Heber EM; Rao M; Cantarelli MA; Itoiz ME; Nigg DW; Calzetta O; Blaumann H; Longhino J; Schwint AE
Radiat Environ Biophys; 2008 Feb; 47(1):147-55. PubMed ID: 17955256
[TBL] [Abstract][Full Text] [Related]
28. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
29. Boron Neutron Capture Therapy (BNCT) Mediated by Maleimide-Functionalized
Monti Hughes A; Goldfinger JA; Palmieri MA; Ramos P; Santa Cruz IS; De Leo L; Garabalino MA; Thorp SI; Curotto P; Pozzi ECC; Kawai K; Sato S; Itoiz ME; Trivillin VA; Guidobono JS; Nakamura H; Schwint AE
Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888170
[TBL] [Abstract][Full Text] [Related]
30. Boron neutron capture therapy (BNCT) for the treatment of liver metastases: biodistribution studies of boron compounds in an experimental model.
Garabalino MA; Monti Hughes A; Molinari AJ; Heber EM; Pozzi EC; Cardoso JE; Colombo LL; Nievas S; Nigg DW; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
Radiat Environ Biophys; 2011 Mar; 50(1):199-207. PubMed ID: 21132507
[TBL] [Abstract][Full Text] [Related]
31. Histamine reduces boron neutron capture therapy-induced mucositis in an oral precancer model.
Monti Hughes A; Pozzi E; Thorp SI; Curotto P; Medina VA; Martinel Lamas DJ; Rivera ES; Garabalino MA; Farías RO; Gonzalez SJ; Heber EM; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
Oral Dis; 2015 Sep; 21(6):770-7. PubMed ID: 25926141
[TBL] [Abstract][Full Text] [Related]
32. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
33. Different oral cancer scenarios to personalize targeted therapy: Boron Neutron Capture Therapy translational studies.
Hughes AM; Goldfinger JA; Santa Cruz IS; Pozzi EC; Thorp S; Curotto P; Garabalino MA; Itoiz ME; Palmieri MA; Ramos P; Heber EM; Aromando RF; Nigg DW; Koivunoro H; Trivillin VA; Schwint AE
Ther Deliv; 2019 Jun; 10(6):353-362. PubMed ID: 31184544
[TBL] [Abstract][Full Text] [Related]
34. The hamster cheek pouch model for field cancerization studies.
Monti-Hughes A; Aromando RF; Pérez MA; Schwint AE; Itoiz ME
Periodontol 2000; 2015 Feb; 67(1):292-311. PubMed ID: 25494606
[TBL] [Abstract][Full Text] [Related]
35. The basis and advances in clinical application of boron neutron capture therapy.
He H; Li J; Jiang P; Tian S; Wang H; Fan R; Liu J; Yang Y; Liu Z; Wang J
Radiat Oncol; 2021 Nov; 16(1):216. PubMed ID: 34743756
[TBL] [Abstract][Full Text] [Related]
36. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
37. Microdistributions of prospective BNCT-compound CuTCPH in tissue sections with a heavy ion microbeam.
Stoliar P; Kreiner AJ; Debray ME; Caraballo ME; Valda AA; Davidson J; Davidson M; Kesque JM; Somacal H; DiPaolo H; Burlon AA; Ozafrán MJ; Vázquez ME; Minsky D; Heber EM; Trivillin VA; Schwint AE
Appl Radiat Isot; 2004 Nov; 61(5):771-4. PubMed ID: 15308142
[TBL] [Abstract][Full Text] [Related]
38. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y
Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201
[TBL] [Abstract][Full Text] [Related]
39. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
40. Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.
Iwakura M; Kondoh H; Hiratsuka J; Ehara K; Tamaki N; Mishima Y
Pigment Cell Res; 2002 Feb; 15(1):67-75. PubMed ID: 11837459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
